Why is Caplin Point Lab falling/rising?

As of 11-Sep, Caplin Point Laboratories Ltd is experiencing a price increase, currently at Rs 2,236.60, reflecting a rise of Rs 25.25 or 1.14%. The stock has shown strong performance recently, gaining 5.81% over the past week and outperforming its sector by 0.67% today. It has also been on a consecutive gain streak for the last five days, with a notable intraday high of Rs 2,270. The stock is trading above its moving averages across various time frames, indicating positive momentum. Additionally, the company has demonstrated high management efficiency with a return on equity (ROE) of 19.84%, a low debt-to-equity ratio, and has reported positive results for the last 12 consecutive quarters, which has likely bolstered investor confidence.
In the broader market context, Caplin Point Laboratories Ltd has outperformed the Sensex over the past week, with a return of 5.81% compared to the Sensex's 1.03%. The stock's performance over the last year has also been strong, yielding a return of 13.53%, while the benchmark has only seen a marginal increase of 0.03%. The increasing participation of institutional investors, who have raised their stake in the company, further supports the stock's upward movement, as these investors typically have the resources to analyze the company's fundamentals more effectively than retail investors. Overall, the combination of strong financial performance, positive investor sentiment, and favorable market conditions has contributed to the stock's rising price.